Cite
Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
MLA
Hu, Li-Yang, et al. “Expression and Clinical Value of Programmed Cell Death-Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma: A Retrospective Study.” Chinese Journal of Cancer, vol. 36, no. 1, Dec. 2017, p. 94. EBSCOhost, https://doi.org/10.1186/s40880-017-0262-z.
APA
Hu, L.-Y., Xu, X.-L., Rao, H.-L., Chen, J., Lai, R.-C., Huang, H.-Q., Jiang, W.-Q., Lin, T.-Y., Xia, Z.-J., & Cai, Q.-Q. (2017). Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study. Chinese Journal of Cancer, 36(1), 94. https://doi.org/10.1186/s40880-017-0262-z
Chicago
Hu, Li-Yang, Xiao-Lu Xu, Hui-Lan Rao, Jie Chen, Ren-Chun Lai, Hui-Qiang Huang, Wen-Qi Jiang, Tong-Yu Lin, Zhong-Jun Xia, and Qing-Qing Cai. 2017. “Expression and Clinical Value of Programmed Cell Death-Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma: A Retrospective Study.” Chinese Journal of Cancer 36 (1): 94. doi:10.1186/s40880-017-0262-z.